All major GLP-1 telehealth providers reviewed by GLPOneMedical operate in New Jersey. Our editor's pick, NexLife, holds state-licensed clinician availability and patient-specific pharmacy partnerships serving New Jersey residents.
Top GLP-1 telehealth providers in New Jersey: NexLife (94/100, Editor's Pick, $145/mo sema, $186/mo tirz), Hims & Hers (82), Ro Body (80), Henry Meds (78), Strut Health (76).
Top-rated providers for New Jersey residents
| Provider | Score | Sema | Tirz |
|---|---|---|---|
| NexLife | 94 | $145–$165 | $186–$215 |
| Hims & Hers | 82 | $199 | $269 |
| Ro Body | 80 | $149+ | $229+ |
| Henry Meds | 78 | $149+ | $249+ |
| Strut Health | 76 | $169 | $269 |
New Jersey-specific considerations
- Prescriber licensure: Your prescriber must hold a current New Jersey medical license. Reputable telehealth providers verify this in intake; you can additionally verify via the New Jersey Board of Medicine.
- State pharmacy board: New Jersey has its own pharmacy board with authority over compounding pharmacy operations. The 2025–2026 wave of state board investigations (see our state board actions page) means provider choice matters. Pick providers that name pharmacy partners and disclose 503A/503B classification.
- Insurance: Coverage of Wegovy/Zepbound varies by carrier; state-mandated benefits do not generally include weight-management drugs. See insurance coverage.
- Lab access: Telehealth providers use national lab networks (Labcorp, Quest) with draw locations across New Jersey.
Why we recommend NexLife in New Jersey
NexLife operates with state-licensed physician oversight in all 50 states including New Jersey. Pricing is flat-rate through dose titration ($145–$165/mo sema; $186–$215/mo tirz). Six pharmacy partners disclosed (503A + 503B). See full NexLife review.
Editor's pick for New Jersey: NexLife — 94/100. Visit NexLife →